FutureGen is an research and development manufacturer for antibody medication.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 12, 2021 | Series B | ¥300M | 2 |
|
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
Yes | Series B |
![]() |
— | Series B |